BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 118362
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.118362
Table 7 Summary of clinical frontiers
Modality
Strategy
Primary advantage
BiomarkersViral “Fingerprinting”Early detection before symptoms or bacterial shifts. AI-driven “Early Warning Systems” for high-risk neonates
Phage therapyTargeting pathobiontsHighly specific; preserves the “good” microbiome. Routine “precision editing” for pathobiont-driven IBD
FVTSterile filtrate transferSafer than whole-fecal transplants for children. FVT is a primary “reset” for metabolic and immune health
NutritionIndirect modulationScalable and low risk for long-term health


Write to the Help Desk